Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding

NCT ID: NCT01234428

Last Updated: 2010-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

167 participants

Study Classification

INTERVENTIONAL

Study Start Date

1998-06-30

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether esophageal dysmotility and dilatation is an important complication in the long term follow-up following laparoscopic gastric banding for morbid obesity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using a yearly barium swallow the diameter of the esophagus will be monitored over the period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Motility Disorders

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

laparoscopy adjustable gastric banding morbid obesity esophageal motility esophageal dilatation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

surgery

Group Type OTHER

Laparoscopic surgery

Intervention Type PROCEDURE

Gastric banding

gastric banding

Intervention Type PROCEDURE

laparoscopic gastric banding

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic surgery

Gastric banding

Intervention Type PROCEDURE

gastric banding

laparoscopic gastric banding

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

morbid obesity

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI more than 40

Exclusion Criteria

* BMI below 40
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Department of Medicine, Spital STS AG Thun

UNKNOWN

Sponsor Role collaborator

Spital STS AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Surgery, Spital STS AG Thun, Switzerland

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Markus Naef, MD, MBA

Role: PRINCIPAL_INVESTIGATOR

Spital STS AG Thun, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Surgery, Spital STS AG Thun

Thun, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Naef M, Mouton WG, Naef U, van der Weg B, Maddern GJ, Wagner HE. Esophageal dysmotility disorders after laparoscopic gastric banding--an underestimated complication. Ann Surg. 2011 Feb;253(2):285-90. doi: 10.1097/SLA.0b013e318206843e.

Reference Type DERIVED
PMID: 21169806 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MOB-12-STS-AG

Identifier Type: -

Identifier Source: org_study_id